Bigul

Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Regulations')

As per the Disclosure made by the Company vide its letter dated August 13, 2018 the Company was to complete acquisition of 51% stake in the Equity Share Capital of Windlas Healthcare Private Limited by the end of September, 2018. We hereby disclose that certain condition precedents are still under completion and thus the Company expects the transaction closing to take place on or before October 31, 2018.
01-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Announcement under Regulation 30 (LODR) - Press Release - Zydus Receives final approval from USFDA for Desoximetasone Cream USP.
01-10-2018
Bigul

Cadila Healthcare plans to launch 50 products in US market in FY19

Of over 140 products in pipeline, at least 10 are para IV filings
17-09-2018
Bigul

Cadila Healthcare: A pain reliever

Focus on the high-margin products and launches lined up in the US are key drivers
15-09-2018
Bigul

Zydus Cadila gets USFDA nod to market osteoporosis drug

Drug firm Zydus Cadila has received a final nod from the US health regulator for Risedronate Sodium delayed-release tablets, used for the treatment o
13-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives final approval from the USFDA for Risedronate Sodium Delayed-Release Tablets
13-09-2018
Bigul

Company news: Zydus Cadila

Zydus Cadila has received tentative approval from the United States Food and Drug Administration (USFDA) for Sitagliptin tablets for sale in the US
11-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives tentative approval from the USFDA for Sitagliptin Tablets
11-09-2018
Bigul

Zydus Cadila gets USFDA nod for antiviral drug

Zydus Cadila has received final approval from the US health regulator to market Acyclovir injection, used to treat infections caused by herpes virus,
05-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives final approval from the USFDA for Acyclovir Sodium Injection
05-09-2018
Next Page
Close

Let's Open Free Demat Account